Ozempic, Wegovy Might Lower Colon Cancer Risk
WEDNESDAY, Jan. 7, 2026 — Ozempic and Wegovy might help people avoid colon cancer as well as promote weight loss or control diabetes, a new study says.People who took a GLP-1 drug were 36% less likely to get colon cancer than people who took a…
Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases
Nature Communications, Published online: 07 January 2026; doi:10.1038/s41467-025-67701-9 This umbrella review synthesizes the evidence for safety and efficacy GLP-1 receptor agonists on multiple outcomes including but not limited to metabolic, cardiovascular and renal outcomes.
One food that could help you prevent weight regain
Long-term studies of GLP-1 drugs show that once people stop taking them, they regain more than half of the weight they lost
The affordable food that triggers the body’s own GLP-1
Post Content
How eggs can help you come off Wegovy – cracking the problem of weight-regain – The Conversation
How eggs can help you come off Wegovy – cracking the problem of weight-regain The Conversation How GLP1 drugs work on body and brain against obesity 6abc Philadelphia I Stopped Ozempic and Mounjaro Due to the Cost. thekit.ca Should I consider taking a GLP-1 medication for weight loss? Bethesda Magazine Q&A: How can new drugs help weight loss resolutions […]
Mindy Kaling looks unrecognizable flaunting 40lb weight loss in black cut-out gown at Golden Eve event
The 46-year-old Running Point co-creator has never admitted to taking a trendy GLP-1 agonist drug like Ozempic
From injectables to pills: how the new Wegovy tablet will change the weight loss market forever
The launch of an oral semaglutide pill approved for weight loss represents a new frontier for GLP-1 drugs. Katie Rosseinsky looks at how the landscape is changing
Obesity rings in New Year with Lilly-Nimbus $1.3B deal, RNAi data
Biopharma industry zeal for obesity therapeutics does not appear to be dying down any time soon, with Eli Lilly and Co. entering a $1.3 billion deal with Nimbus Therapeutics LLC for a new small molecule, and Arrowhead Pharmaceuticals Inc. rolling out phase I/IIa data of its RNAi therapeutics used in combination with Lilly’s GLP-1/GIP receptor […]
GLP-1 Use Linked to Lower Colon Cancer Risk vs Aspirin
(MedPage Today) — SAN FRANCISCO — Patients with a history of GLP-1 receptor agonist treatment had a significantly lower risk of developing colorectal cancer (CRC) as compared with those who took aspirin, according to a retrospective study reported…
Drugmakers Fight Multifront Legal Battles Over GLP-1s
In the wake of U.S. Food and Drug Administration approvals for GLP-1 weight-loss drugs, surging public demand and massive profits have inspired a broad range of drugmaker litigation against competitors, alleged counterfeits and telehealth providers.